Chen X - Search Results

1

Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.

Zhang H, Shen Z, Lin Y, Zhang J, Zhang Y, Liu P, Zeng H, Yu M, Chen X, Ning L, Mao X, Cen L, Yu C, Xu C. Zhang H, et al. Among authors: chen x. J Biol Chem. 2020 Mar 20;295(12):3891-3905. doi: 10.1074/jbc.RA119.011487. Epub 2020 Feb 12. J Biol Chem. 2020. PMID: 32051143 Free PMC article.

2

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway.

Chen XY, Cai CZ, Yu ML, Feng ZM, Zhang YW, Liu PH, Zeng H, Yu CH. Chen XY, et al. World J Gastroenterol. 2019 Dec 7;25(45):6607-6618. doi: 10.3748/wjg.v25.i45.6607. World J Gastroenterol. 2019. PMID: 31832001 Free PMC article.

3

GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration.

Zhang Y, Zhou X, Liu P, Chen X, Zhang J, Zhang H, Li S, Chen Y, Song X, Wang J, Zeng H, Zhang X, Tang C, Yu C, Li Y, Xu C. Zhang Y, et al. Among authors: chen x, chen y. Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G531-G542. doi: 10.1152/ajpgi.00342.2020. Epub 2021 Jan 20. Am J Physiol Gastrointest Liver Physiol. 2021. PMID: 33470903 Free article.

4

Vitamin D receptor inhibits EMT via regulation of the epithelial mitochondrial function in intestinal fibrosis.

Yu M, Wu H, Wang J, Chen X, Pan J, Liu P, Zhang J, Chen Y, Zhu W, Tang C, Jin Q, Li C, Lu C, Zeng H, Yu C, Sun J. Yu M, et al. Among authors: chen x, chen y. J Biol Chem. 2021 Jan-Jun;296:100531. doi: 10.1016/j.jbc.2021.100531. Epub 2021 Mar 11. J Biol Chem. 2021. PMID: 33713706 Free PMC article.

5

Insulin-like growth factor binding protein 1 ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease.

Pan J, Cen L, Zhou T, Yu M, Chen X, Jiang W, Li Y, Yu C, Shen Z. Pan J, et al. Among authors: chen x. J Gastroenterol Hepatol. 2021 Dec;36(12):3438-3447. doi: 10.1111/jgh.15627. Epub 2021 Jul 30. J Gastroenterol Hepatol. 2021. PMID: 34273192

6

The DEAD-box helicase DDX3x ameliorates non-alcoholic fatty liver disease via mTORC1 signalling pathway.

Liu P, Zhang Y, Tang C, Cen L, Chen Y, Li S, Chen X, Yu M, Zhang J, Zhang X, Zeng H, Xu C, Yu C. Liu P, et al. Among authors: chen x, chen y. Liver Int. 2022 Aug;42(8):1793-1802. doi: 10.1111/liv.15278. Epub 2022 May 18. Liver Int. 2022. PMID: 35460172

7

Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Cai C, Song X, Chen Y, Chen X, Yu C. Cai C, et al. Among authors: chen x, chen y. Hepatol Int. 2020 Jan;14(1):115-126. doi: 10.1007/s12072-019-09964-1. Epub 2019 Jul 9. Hepatol Int. 2020. PMID: 31290072 Free PMC article.

8

Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway.

Chen Y, Chen X, Gao J, Xu C, Xu P, Li Y, Zhu Y, Yu C. Chen Y, et al. Among authors: chen x. FASEB J. 2019 Oct;33(10):11411-11419. doi: 10.1096/fj.201900643RRR. Epub 2019 Jul 16. FASEB J. 2019. PMID: 31311301

In NAFLD mice, FLRL2 enhancement alleviated steatosis, activated the Arntl-Sirt1 axis, and inhibited lipogenesis, ER stress, and inflammation, providing preliminary evidence of the benefits of FLRL2-mediated gene therapy in NAFLD.-Chen, Y., Chen, X., Gao, J., …

In NAFLD mice, FLRL2 enhancement alleviated steatosis, activated the Arntl-Sirt1 axis, and inhibited lipogenesis, ER stress, and inflammatio …

9

Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction.

Zhang X, Lin Y, Lin S, Li C, Gao J, Feng Z, Wang J, Zhang J, Zhang H, Zhang Y, Chen X, Chen S, Xu C, Li Y, Yu C, Zeng H. Zhang X, et al. Among authors: chen s, chen x. Hepatol Int. 2020 Sep;14(5):828-841. doi: 10.1007/s12072-020-10068-4. Epub 2020 Jun 30. Hepatol Int. 2020. PMID: 32607732 Free PMC article.

10

Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population.

Chen Y, Chen X, Chen Q, Yu C. Chen Y, et al. Among authors: chen q, chen x. Front Endocrinol (Lausanne). 2021 Apr 22;12:565714. doi: 10.3389/fendo.2021.565714. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33967948 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115,530 results

Search Page

Filters